About
Neurological Drugs
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (22)
View allTotal Trials
22
As Lead Sponsor
22
As Collaborator
0
By Phase
PHASE3: 10PHASE2: 5PHASE1: 4PHASE2/PHASE3: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 16TERMINATED: 3NOT_YET_RECRUITING: 1UNKNOWN: 1]ß-CIT SPECT Single Photon Emission Computerized Tomography (SPECT) to Evaluate Dopamine and Serotonin Transporter Occupancy by Safinamide in Parkinson Disease Patients": 1
Clinical Trials Pipeline22 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07184619Lead Sponsor
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
PHASE3Not yet recruiting
Started: Oct 15, 2025 · Completed: Sep 1, 2026
NCT04461119Lead Sponsor
Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
PHASE2Completed
Started: Jun 16, 2020 · Completed: Mar 13, 2021
NCT03446274Lead Sponsor
An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects
PHASE1Unknown
Started: Apr 2, 2018 · Completed: Jun 30, 2018
NCT02790034Lead Sponsor
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
PHASE2/PHASE3Terminated
Started: Oct 26, 2016 · Completed: May 4, 2020
NCT02624167Lead Sponsor
A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
PHASE2Completed
Started: Dec 31, 2015 · Completed: Jan 31, 2017
Locations (1)
Headquarters
Bresso, Italy
Map
Loading map...